🇺🇸 FDA
Pipeline program

High risk experimental group

2024-KLS-039-02

Unknown gene_therapy active

Quick answer

High risk experimental group for Adolescent Idiopathic Scoliosis is a Unknown program (gene_therapy) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Adolescent Idiopathic Scoliosis
Phase
Unknown
Modality
gene_therapy
Status
active

Clinical trials